Depreciation in USD of Akebia Therapeutics, Inc. from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Akebia Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to Q1 2025.
  • Akebia Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $314K, a 13.7% decline year-over-year.
  • Akebia Therapeutics, Inc. annual Depreciation for 2024 was $1.46M, a 7.76% decline from 2023.
  • Akebia Therapeutics, Inc. annual Depreciation for 2023 was $1.59M, a 4.17% decline from 2022.
  • Akebia Therapeutics, Inc. annual Depreciation for 2022 was $1.65M, a 12.9% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Akebia Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $314K -$50K -13.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $364K -$34K -8.54% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $398K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2020 $2.1M $600K $0 0% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
Q3 2020 $2.1M $500K -$100K -16.7% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.2M $500K -$100K -16.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.3M $500K +$100K +25% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $2.2M $600K +$300K +100% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.9M $600K +$400K +200% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.5M $600K +$400K +200% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.1M $400K +$200K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $900K $300K +$100K +50% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $800K $200K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $800K $200K +$100K +100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $700K $200K +$100K +100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $600K $200K +$78K +63.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $522K $200K +$100K +100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $422K $100K +$54K +117% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $368K $100K +$68K +213% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $300K $122K +$112K +1120% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-26
Q3 2016 $188K $100K +$65K +186% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $123K $46K +$14K +43.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $109K $32K +$13K +68.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $96K $10K -$6.03K -37.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $102K $35K +$22K +169% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $80K $32K +$20K +167% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $60K $19K +$11K +138% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $49K $16K +$15.1K +1545% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 $33.9K $13K +$13K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $21K $12K +$12K Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $9K $8K +$8K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $1K $974 Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $26.00* Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12

Akebia Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.46M -$123K -7.76% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $1.59M -$69K -4.17% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $1.65M -$246K -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.9M -$200K -9.52% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $2.1M -$100K -4.55% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 $2.2M +$1.3M +144% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $900K +$300K +50% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $600K +$300K +100% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $300K +$204K +213% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
2015 $96K +$47K +95.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $49K +$48K +4800% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 $1K +$1K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $0 Jan 1, 2012 Dec 31, 2012 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.